Skip to main content
RecallRadar
FDAClass II

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only,… Recalled: Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg,… was recalled on July 8, 2026 in cooperation with the U.S. Food and Drug Administration because failed Dissolution Specifications; Olmesartan Medoxomil content below specifications.

Is my unit affected?

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC., Parsnippany, NJ 07054. NDC: 67877-500-30

Model, lot & date codes to check

Lot 25121311, expiry 3/31/2028

Units affected: 6,192 bottles

Where it was sold: Nationwide in the USA

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

Class II means the product might cause a temporary or medically reversible health problem; the chance of serious harm is remote.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: Ascend Laboratories, LLC

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.